• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压性肾硬化症患者短期严格血压控制后肾功能的长期改善

Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis.

作者信息

Pettinger W A, Lee H C, Reisch J, Mitchell H C

机构信息

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.

出版信息

Hypertension. 1989 Jun;13(6 Pt 2):766-72. doi: 10.1161/01.hyp.13.6.766.

DOI:10.1161/01.hyp.13.6.766
PMID:2544523
Abstract

Seventy-nine hypertensive nephrosclerosis patients entered a prospective randomized single-blind study to 1) establish the pattern of decay of renal function in this population and the variability therein and 2) to determine if strict diastolic blood pressure (DBP) control (less than or equal to 80 mm Hg) is more effective than conventional levels (90-95 mm Hg) in conserving renal function. Because of unexpected significant improvement in renal function in patients from both groups, which changed the perspectives on the course of this disease as described herein, this report is being published before completion of the trial. The selection criteria were 1) serum creatinine concentration of 1.6-7.0 mg/dl, 2) glomerular filtration rate of less than 70 ml/min/1.73 m2, and 3) absence of diseases (other than hypertension) known to destroy renal function. Renal function was assessed by glomerular filtration rate [( 125I]iothalamate clearance) and serum creatinine concentration. Before randomization, DBP was aggressively treated to reduce it to less than 80 mm Hg. Twenty-two subjects (14 in the strict DBP control group and eight in the conventional DBP control group) have been enrolled in the study for 36 months. In contrast to results from previous studies in humans and rats, renal function improved in both patient groups. Thus, irrevocable progression of renal damage after onset of renal failure from high blood pressure does not necessarily occur, and in fact, long-term improvement of renal function resulted from the effects of the study itself.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

79名高血压肾硬化患者参与了一项前瞻性随机单盲研究,目的是:1)确定该人群肾功能衰退模式及其变异性;2)确定严格控制舒张压(DBP)(小于或等于80mmHg)在保护肾功能方面是否比传统水平(90 - 95mmHg)更有效。由于两组患者的肾功能均出现意外的显著改善,这改变了本文所述疾病进程的观点,因此本报告在试验完成前发表。入选标准为:1)血清肌酐浓度为1.6 - 7.0mg/dl;2)肾小球滤过率小于70ml/min/1.73m²;3)无已知会破坏肾功能的疾病(高血压除外)。通过肾小球滤过率([¹²⁵I]碘肽酸盐清除率)和血清肌酐浓度评估肾功能。在随机分组前,积极治疗DBP以将其降至80mmHg以下。22名受试者(严格DBP控制组14名,传统DBP控制组8名)已参与该研究36个月。与之前人类和大鼠研究的结果相反,两组患者的肾功能均有所改善。因此,高血压导致肾衰竭后肾损伤不一定会不可逆转地进展,事实上,研究本身的效应带来了肾功能的长期改善。(摘要截短至250字)

相似文献

1
Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis.高血压性肾硬化症患者短期严格血压控制后肾功能的长期改善
Hypertension. 1989 Jun;13(6 Pt 2):766-72. doi: 10.1161/01.hyp.13.6.766.
2
Hyperfiltration and conservation of renal function in hypertensive nephrosclerosis patients.
Am J Kidney Dis. 1993 Apr;21(4 Suppl 1):68-74. doi: 10.1016/0272-6386(93)70076-b.
3
"Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis.“严格”血压控制与高血压性肾硬化症中肾脏疾病的进展
Kidney Int. 1995 Sep;48(3):851-9. doi: 10.1038/ki.1995.361.
4
Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis.
Ann Intern Med. 1991 Oct 1;115(7):513-9. doi: 10.7326/0003-4819-115-7-513.
5
Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.马尼地平与依那普利单药治疗高血压合并2型糖尿病患者的多中心、随机、双盲、24周研究。
Clin Ther. 2005 Feb;27(2):166-73. doi: 10.1016/j.clinthera.2005.02.001.
6
ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis.
Hypertension. 2001 Sep;38(3 Pt 2):645-9. doi: 10.1161/hy09t1.096184.
7
A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.一项关于伊拉地平与螺普利作为单一疗法及联合疗法对慢性肾衰竭合并高血压患者肾功能下降影响的随机双盲对照研究。
Clin Nephrol. 2001 May;55(5):375-83.
8
Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: a one-year, prospective, randomized study.
Am J Hypertens. 2000 Sep;13(9):980-5. doi: 10.1016/s0895-7061(00)00287-9.
9
Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.钙通道阻滞剂尼群地平对肾血管性高血压大鼠肾硬化的不良反应。
Hypertension. 1992 Aug;20(2):233-41. doi: 10.1161/01.hyp.20.2.233.
10
Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.血压控制和降压药物治疗方案对肾小球滤过率的短期影响:非裔美国人肾脏疾病与高血压试验研究
Am J Kidney Dis. 1997 May;29(5):720-8. doi: 10.1016/s0272-6386(97)90125-6.

引用本文的文献

1
Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension.高血压的三大困境与三种解决方案:高血压中的肾脏药理学
J Cardiovasc Pharmacol. 2017 Mar;69(3):129-139. doi: 10.1097/FJC.0000000000000458.
2
Short-term hypertension management in community is associated with long-term risk of stroke and total death in China: A community controlled trial.中国社区短期高血压管理与中风及全因死亡的长期风险相关:一项社区对照试验。
Medicine (Baltimore). 2016 Nov;95(48):e5245. doi: 10.1097/MD.0000000000005245.
3
Estimated glomerular filtration rate reversal by blood pressure lowering in chronic kidney disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD study.
降压对慢性肾脏病患者估计肾小球滤过率的逆转作用:日本心血管疾病多中心慢性肾脏病研究。
J Clin Hypertens (Greenwich). 2013 Mar;15(3):171-5. doi: 10.1111/jch.12054. Epub 2012 Dec 14.
4
Renal protection and antihypertensive drugs: current status.肾脏保护与抗高血压药物:现状
Drugs. 1999 May;57(5):665-93. doi: 10.2165/00003495-199957050-00002.
5
ACE inhibitors in elderly patients with hypertension. Special considerations.老年高血压患者使用血管紧张素转换酶抑制剂。特殊注意事项。
Drugs Aging. 1996 Jan;8(1):29-37. doi: 10.2165/00002512-199608010-00006.
6
Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo.氨氯地平对轻至中度高血压患者肾脏血流动力学的影响。一项与安慰剂对照的随机对照研究。
Eur J Clin Pharmacol. 1993;45(4):307-11. doi: 10.1007/BF00265946.
7
ACE inhibitors in non-diabetic renal disease.非糖尿病肾病中的血管紧张素转换酶抑制剂
Br Heart J. 1994 Sep;72(3 Suppl):S46-51. doi: 10.1136/hrt.72.3_suppl.s46.
8
Do calcium channel blockers have renal protective effects?钙通道阻滞剂有肾脏保护作用吗?
Drugs Aging. 1994 Oct;5(4):263-87. doi: 10.2165/00002512-199405040-00004.
9
Do glomerular hemodynamic adaptations influence the progression of human renal disease?
Pediatr Nephrol. 1991 Jan;5(1):88-93. doi: 10.1007/BF00852855.